Shantanu Nundy, MD, MBA, is a primary care physician, technologist, and business leader who serves as Chief Medical Officer for Accolade, which delivers personalized navigation and population health services to companies that cover over 1.7 million working Americans. In addition, he practices primary care in the greater Washington, DC, area. Dr. Nundy was a senior health specialist at the World Bank Group in its Health, Nutrition, and Population Global Practice, where he advised developing countries across Africa, Asia, and South America on health system innovation and technology. Previously, he was Director of the Human Diagnosis Project, a healthcare AI startup backed by Y Combinator, Andreessen Horowitz, and Union Square Ventures, which he successfully built into the world's largest open medical project spanning 80 countries. Prior to that, he was Managing Director for Clinical Innovation at Evolent Health (NYSE: EVH), a population health and predictive analytics company, where he improved hospital and chronic disease outcomes for over 2 million Americans. He is also co-inventor of SMS-DMCare, an automated text messaging software for individuals with diabetes, one of the first mobile health interventions to demonstrate improved health and lower costs and to be adopted by the World Health Organization (WHO)'s eHealth Compendium. Nundy's work has been recognized by the MacArthur Foundation and been featured in The Wall Street Journal, Forbes, The Atlantic, and Wired. He has been an advisor and speak on digital health and artificial intelligence to the federal and state medical boards, the FDA, and numerous healthcare startups and investors. Nundy is a graduate of MIT (BS), Johns Hopkins (MD), and the University of Chicago (MBA).